Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use*; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D014436:Typhoid-Paratyphoid Vaccines / Q000627:therapeutic use*
D014436:Typhoid-Paratyphoid Vaccines; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide; D008797:Metyrapone